Haemonetics Corporation

05/01/2026 | Press release | Distributed by Public on 05/01/2026 14:18

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 27, 2026, Charles J. Dockendorff informed Haemonetics Corporation (the "Company") that he will not stand for re-election at the Company's 2026 Annual Meeting of Shareholders (the "2026 Annual Meeting"). Mr. Dockendorff has served as a member of the Board of Directors (the "Board") of the Company since 2014 and currently serves as a member of the Audit Committee and the Governance and Compliance Committee. Mr. Dockendorff will continue to serve as a director and in his committee roles until the 2026 Annual Meeting. Mr. Dockendorff's decision not to stand for re-election at the 2026 Annual Meeting is not the result of any disagreement with the Company.
Haemonetics Corporation published this content on May 01, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 01, 2026 at 20:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]